FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: US Considers Rules Allowing American Investment in Chinese Drugs

By

The U.S. Department of Treasury is planning to introduce rules that would allow American pharmaceuticals to invest in the licensing of Chinese drugs, Reuters reported Sept. 18, citing sources.

The rules, which are still subject to change, would cover most of the new drugs under development, except those related to pathogens or biotechnology that can be potentially weaponized, the sources told the news outlet.

The news sparked positive sentiment towards Chinese pharmaceuticals on Monday, with Akeso (HKG:9926) jumping 10%, Sino Biopharmaceutical (HKG:1177) climbing 8%, CSPC Pharmaceutical Group (HKG:1093) rising 7%, Innovent Biologics (HKG:1801) inching 6% higher and HUTCHMED (HKG:0013) increasing 4% at the close.

The U.S. Treasury Department did not immediately respond to' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

What else is happening in Asia?

Asia

Market Chatter: SoftBank Launches $11 Billion Bond Sale to Fund OpenAI Investment

SoftBank Group (TYO:9984) has launched $10 billion and 1 billion euros in senior unsecured notes to fund its investment in OpenAI, Reuters reported Monday, citing a term sheet.The dollar-denominated tranches mature in 3.5, 5.5, and 7.5 years, while the euro portions mature in four and six years, the newswire said.The proceeds will finance SoftBank's $10 billion payment for the third tranche of its OpenAI follow-on investment, expected to close on Oct. 1, while the remaining funds will be used for general corporate purposes, the report said.SoftBank Group did not immediately respond to' request for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

TYO:9984
Asia

Shenzhen Transsion's Hong Kong Listing Application Under Review; Shares Up 4%

Shenzhen Transsion (SHA:688036) said the Hong Kong Exchange is reviewing its application for listing on the Main Board.The listing is pending final approval from the Hong Kong bourse, the city's Securities and Futures Commission, and other regulators, according to a weekend filing with the Shanghai bourse.Shares of the mobile phone maker rose 4% in recent trade.

SHA:688036
Asia

China Approves Shanghai Rural Commercial Bank's Absorption of Peer

Shanghai Rural Commercial Bank (SHA:601825) received approval from China's National Financial Regulatory Administration to absorb Shanghai Chongming Rural Commercial Bank, according to a Saturday filing with the Shanghai bourse.The listed commercial bank will absorb Chongming RCB's assets, liabilities, institutions, businesses, employees, and other rights and obligations and will dissolve Chongming, according to the filing.

SHA:601825